Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Goldman Sachs analyst James Quigley initiated coverage on Sanofi SNY with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
• Raymond James analyst Daniel Tamayo initiated coverage on ACNB Corporation ACNB with an Outperform rating and announced a price target of $47. ACNB shares closed at $41.25 on Thursday. See how other analysts view this stock.
• B. Riley Securities analyst Nick Giles initiated coverage on United States Antimony Corporation UAMY with a Buy rating and announced a price target of $3. United States Antimony shares closed at $1.79 on Thursday. See how other analysts view this stock.
• Maxim Group analyst Jason McCarthy initiated coverage on Anixa Biosciences, Inc. ANIX with a Buy rating and announced a price target of $1. Anixa Biosciences shares closed at $3.15 on Thursday. See how other analysts view this stock.

Considering buying ACNB stock? Here’s what analysts think:

Read This Next:

• Top 2 Defensive Stocks That May Keep You Up At Night In March